Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03218462 · ClinicalTrials.gov registry record · NA
Effect of Sensory Adapted Dental Environment on Dental Anxiety of Children With Intellectual and Developmental Disabilities
A NA study of Intellectual Disability and Developmental Disability, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT03218462: Completed NA study of Intellectual Disability and Developmental Disability, sponsored by Virginia Commonwealth University.
NCT03218462 is a NA study of Intellectual Disability and Developmental Disability that has completed, run by Virginia Commonwealth University. The registered enrollment target is 22 participants, below the 353-participant average among 26 other Intellectual Disability trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03218462, a NA study of Intellectual Disability and Developmental Disability, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
Children with intellectual/developmental disabilities (ID/DD) will experience less dental anxiety and cooperate better in a Sensory Adapted Dental Environment (modified visual, sensory, and somatosensory stimuli in a regular dental setting) than in a regular dental environment (RDE).
Primary Outcome
Measured using Frankl Scale for pediatric dentistry, with 1=definitely negative and 5=definitely positive
Conditions Studied
Interventions
- BEHAVIORAL Sensory Adapted Dental Environment (SADE)
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-07-10 |
| Est. Completion | 2018-03-30 |
| Phase | NA |
What the finished NCT03218462 record still lists
NCT03218462 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 353-participant average among 26 other Intellectual Disability trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Intellectual Disability appearing as the primary indexed condition, and to 1 intervention - of which Sensory Adapted Dental Environment (SADE) is the first listed.
NCT03218462 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03218462 about?
NCT03218462 is a clinical study titled "Effect of Sensory Adapted Dental Environment on Dental Anxiety of Children With Intellectual and Developmental Disabilities". Children with intellectual/developmental disabilities (ID/DD) will experience less dental anxiety and cooperate better in a Sensory Adapted Dental Environment (modified visual, sensory, and somatosensory stimuli in a regular dental setting) than in a regular dental environment (RDE).
What is the current status of trial NCT03218462?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2017-07-10. Estimated completion is 2018-03-30.
What conditions does trial NCT03218462 study?
This clinical trial studies the following conditions: Intellectual Disability, Developmental Disability, Dental Anxiety.
What interventions are being tested in trial NCT03218462?
The interventions under investigation include: Sensory Adapted Dental Environment (SADE) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03218462?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03218462 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intellectual Disability
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03218462's enrollment target sits among peer trials
22 24th of 26 higher than 3 of 26 other Intellectual Disability trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intellectual Disability trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Early Augmentative and Alternative Communication (AAC) Intervention Delivered Via Hybrid Telehealth
RECRUITING · NA
-
Online Learning Module to Advance Research Related to People With Disabilities
RECRUITING · NA
-
Future Planning and Well-Being for Individuals With Intellectual Disabilities and Family Caregivers
RECRUITING · NA
-
Harnessing Communication Preferences
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI